Scientists were able to treat men with benign prostatic hyperplasia (BPH), when prostate is enlarged, but not cancerous.
The new treatment, using radiology, and known as prostate artery embolization (PAE) improved symptoms in patients, irrespective of the size of BPH, as researchers found in later studies.
“This innovative treatment offers less risk, less pain and less recovery time than traditional surgery, and we are hopeful that further research will confirm it to be an effective therapy for BPH,” said lead researcher Sandeep Bagla, interventional radiologist at the Inova Alexandria Hospital in the US.
Scientists led by Bagla looked at 78 patients who went under the new prostate artery embolization procedure (which blocks abnormal blood vessels) for BPH as part of routine practice for clinicians.
In the study, patients were categorized into three analysis groups based on the size of the enlarged prostate as follows: less than 50 cubic centimeters, between 50-80 cubic centimetres and greater than 80 cubic centimetres.
The effectivess of the PAE was assessed for these groups at one, three, and six months following treatment.
As much as 96 percent of cases (75 of 78) received the technically successful decision, with both blood vessels leading to enlarged prostate blocked by PAE treatment.
Patients reported improvements in the quality of life as measured by the American Urological Association Symptom Index for all three groups of patients.
The findings were presented at the Society of Interventional Radiology’s 40th Annual Scientific Meeting at the Georgia World Congress Center in Atlanta.